Endobronchial ultrasound biopsy (EBUS-TBNA) is a minimally invasive procedure used to diagnose mediastinal and hilar lymphadenopathy. EBUS biopsy provides distinct advantages over conventional tissue sampling methods, such as superior visualization of lesions and real-time guidance to access small lesions closer to the trachea and major bronchi.
Market key trends:
The increasing adoption of minimally invasive biopsy procedures is expected to aid the growth of the endobronchial ultrasound biopsy market over the forecast period. Minimally invasive procedures are associated with benefits such as reduced postoperative complications, smaller incisions, shorter hospital stay, and quicker recovery in comparison to traditional open surgeries. EBUS biopsy is a minimally invasive procedure that has proven to be highly accurate for staging and sampling of lung cancer. Moreover, EBUS biopsy minimizes trauma to adjacent structures and helps in quicker diagnosis. Growing public awareness about benefits of minimally invasive procedures over conventional open surgeries is expected to drive the adoption of endobronchial ultrasound biopsy.
Segment Analysis
The global endobronchial ultrasound biopsy market is dominated by endobronchial biopsy needles sub segment due to growing demand for minimally invasive procedures for lung biopsy sampling. Endobronchial biopsy needles account for over 45% of the total market share owing to various advantages such as real time imaging, easy navigation and sampling of lesions beyond visible airways.
Key Takeaways
Global Endobronchial Ultrasound Biopsy Market Size is expected to witness high growth during the forecast period of 2023 to 2030. The market is projected to reach a value of US$ 722.67 Bn by 2024 growing at a CAGR of 7.4% through 2030.
Regional analysis: Asia Pacific region is expected to be the fastest growing regional market for endobronchial ultrasound biopsy growing at around 9% CAGR owing to rising healthcare expenditure, increasing lung cancer incidence and growing medical tourism in countries like India and China. North America currently dominates the market with over 35% share led by robust healthcare infrastructure and availability of advanced diagnostic procedures in the US and Canada.
Key players operating in the endobronchial ultrasound biopsy market are Alf Engineering, F TECH, Magna International, Metalsa, Nissin Kogyo, Sango Co., Ltd., Tata Precision Tubes, Tenneco, Thyssenkrupp AG, Vari-Form, and Yorozu. The market is consolidated in nature with top 5 players accounting for over 55% share. Players are focused on new product launches and geographic expansion strategies to gain competitive edge.
Get More Insights On This Topic: https://www.ukwebwire.com/global-endobronchial-ultrasound-biopsy-market-share/
Comments
0 comment